FDA Inspection 1077022 — Carter BloodCare - Rosedale
The FDA completed an inspection of Carter BloodCare - Rosedale on Jan 16, 2019 in Fort Worth, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 16, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Worth, TX (United States)